| Year |
Citation |
Score |
| 2024 |
Belov V, Erwin-Grabner T, Aghajani M, Aleman A, Amod AR, Basgoze Z, Benedetti F, Besteher B, Bülow R, Ching CRK, Connolly CG, Cullen K, Davey CG, Dima D, Dols A, ... ... Reneman L, et al. Multi-site benchmark classification of major depressive disorder using machine learning on cortical and subcortical measures. Scientific Reports. 14: 1084. PMID 38212349 DOI: 10.1038/s41598-023-47934-8 |
0.666 |
|
| 2023 |
Boucherie DE, Reneman L, Booij J, Martins D, Dipasquale O, Schrantee A. Modulation of functional networks related to the serotonin neurotransmitter system by citalopram: Evidence from a multimodal neuroimaging study. Journal of Psychopharmacology (Oxford, England). 2698811231211154. PMID 37947344 DOI: 10.1177/02698811231211154 |
0.687 |
|
| 2023 |
Boucherie DE, Reneman L, Ruhé HG, Schrantee A. Neurometabolite changes in response to antidepressant medication: A systematic review of H-MRS findings. Neuroimage. Clinical. 40: 103517. PMID 37812859 DOI: 10.1016/j.nicl.2023.103517 |
0.627 |
|
| 2023 |
Breedt LC, Santos FAN, Hillebrand A, Reneman L, van Rootselaar AF, Schoonheim MM, Stam CJ, Ticheler A, Tijms BM, Veltman DJ, Vriend C, Wagenmakers MJ, van Wingen GA, Geurts JJG, Schrantee A, et al. Multimodal multilayer network centrality relates to executive functioning. Network Neuroscience (Cambridge, Mass.). 7: 299-321. PMID 37339322 DOI: 10.1162/netn_a_00284 |
0.655 |
|
| 2022 |
van Genderen JG, Chia C, Van den Hof M, Mutsaerts HJMM, Reneman L, Pajkrt D, Schrantee A. Brain Differences in Adolescents Living With Perinatally Acquired HIV Compared to Adoption Status Match Controls: A Cross-Sectional Study. Neurology. PMID 35940898 DOI: 10.1212/WNL.0000000000200946 |
0.621 |
|
| 2022 |
Kaiser A, Broeder C, Cohen JR, Douw L, Reneman L, Schrantee A. Effects of a single-dose methylphenidate challenge on resting-state functional connectivity in stimulant-treatment naive children and adults with ADHD. Human Brain Mapping. PMID 35781371 DOI: 10.1002/hbm.25981 |
0.81 |
|
| 2022 |
Batelaan NM, Seldenrijk A, van den Heuvel OA, van Balkom AJLM, Kaiser A, Reneman L, Tan HL. Anxiety, Mental Stress, and Sudden Cardiac Arrest: Epidemiology, Possible Mechanisms and Future Research. Frontiers in Psychiatry. 12: 813518. PMID 35185641 DOI: 10.3389/fpsyt.2021.813518 |
0.726 |
|
| 2022 |
Kaiser A, Reneman L, Solleveld MM, Coolen BF, Scherder EJA, Knutsson L, Bjørnerud A, van Osch MJP, Wijnen JP, Lucassen PJ, Schrantee A. A Randomized Controlled Trial on the Effects of a 12-Week High- vs. Low-Intensity Exercise Intervention on Hippocampal Structure and Function in Healthy, Young Adults. Frontiers in Psychiatry. 12: 780095. PMID 35126199 DOI: 10.3389/fpsyt.2021.780095 |
0.777 |
|
| 2021 |
de Ruiter MB, Reneman L, Kieffer JM, Oldenburg HSA, Schagen SB. Brain White Matter Microstructure as a Risk Factor for Cognitive Decline After Chemotherapy for Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 39: 3908-3917. PMID 34591652 DOI: 10.1200/JCO.21.00627 |
0.74 |
|
| 2021 |
Kaiser A, Reneman L, Lucassen PJ, de Vries TJ, Schrantee A, Kaag AM. Targeting working memory to modify emotional reactivity in adult attention deficit hyperactivity disorder: a functional magnetic resonance imaging study. Brain Imaging and Behavior. PMID 34524649 DOI: 10.1007/s11682-021-00532-6 |
0.79 |
|
| 2021 |
Campos AI, Thompson PM, Veltman DJ, Pozzi E, van Veltzen LS, Jahanshad N, Adams MJ, Baune BT, Berger K, Brosch K, Bülow R, Connolly CG, Dannlowski U, Davey CG, de Zubicaray GI, ... ... Reneman L, et al. Brain Correlates of Suicide Attempt in 18,925 Participants Across 18 International Cohorts. Biological Psychiatry. PMID 34172278 DOI: 10.1016/j.biopsych.2021.03.015 |
0.655 |
|
| 2021 |
Opel N, Thalamuthu A, Milaneschi Y, Grotegerd D, Flint C, Leenings R, Goltermann J, Richter M, Hahn T, Woditsch G, Berger K, Hermesdorf M, McIntosh A, Whalley HC, Harris MA, ... ... Reneman L, et al. Correction: Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders. Molecular Psychiatry. PMID 34158622 DOI: 10.1038/s41380-021-01191-1 |
0.659 |
|
| 2021 |
Reneman L, van der Pluijm M, Schrantee A, van de Giessen E. Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imaging. European Journal of Radiology. 140: 109752. PMID 34004428 DOI: 10.1016/j.ejrad.2021.109752 |
0.625 |
|
| 2021 |
Tahmasian M, Aleman A, Andreassen OA, Arab Z, Baillet M, Benedetti F, Bresser T, Bright J, Chee MWL, Chylinski D, Cheng W, Deantoni M, Dresler M, Eickhoff SB, Eickhoff CR, ... ... Reneman L, et al. ENIGMA-Sleep: Challenges, opportunities, and the road map. Journal of Sleep Research. e13347. PMID 33913199 DOI: 10.1111/jsr.13347 |
0.552 |
|
| 2021 |
Postema MC, Hoogman M, Ambrosino S, Asherson P, Banaschewski T, Bandeira CE, Baranov A, Bau CHD, Baumeister S, Baur-Streubel R, Bellgrove MA, Biederman J, Bralten J, Brandeis D, Brem S, ... ... Reneman L, et al. Analysis of structural brain asymmetries in attention-deficit/hyperactivity disorder in 39 datasets. Journal of Child Psychology and Psychiatry, and Allied Disciplines. PMID 33748971 DOI: 10.1111/jcpp.13396 |
0.623 |
|
| 2021 |
Tamminga HGH, Reneman L, Schrantee A, Bottelier MA, Bouziane C, Geurts HM, Groenman AP. Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 46: 1-13. PMID 33735707 DOI: 10.1016/j.euroneuro.2021.02.002 |
0.803 |
|
| 2020 |
Patel Y, Parker N, Shin J, Howard D, French L, Thomopoulos SI, Pozzi E, Abe Y, Abé C, ... ... Reneman L, et al. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders. Jama Psychiatry. PMID 32857118 DOI: 10.1001/Jamapsychiatry.2020.2694 |
0.683 |
|
| 2020 |
Mzayek Y, de Ruiter MB, Oldenburg HSA, Reneman L, Schagen SB. Measuring decline in white matter integrity after systemic treatment for breast cancer: omitting skeletonization enhances sensitivity. Brain Imaging and Behavior. PMID 32705463 DOI: 10.1007/S11682-020-00319-1 |
0.759 |
|
| 2020 |
Solleveld MM, Schrantee A, Homberg JR, Lucassen PJ, Reneman L. The influence of age-of-onset of antidepressant use on the acute CBF response to a citalopram challenge; a pharmacological MRI study. Psychiatry Research. Neuroimaging. 303: 111126. PMID 32592855 DOI: 10.1016/J.Pscychresns.2020.111126 |
0.741 |
|
| 2020 |
Boedhoe PSW, van Rooij D, Hoogman M, Twisk JWR, Schmaal L, Abe Y, Alonso P, Ameis SH, Anikin A, Anticevic A, Arango C, Arnold PD, Asherson P, Assogna F, Auzias G, ... ... Reneman L, et al. Subcortical Brain Volume, Regional Cortical Thickness, and Cortical Surface Area Across Disorders: Findings From the ENIGMA ADHD, ASD, and OCD Working Groups. The American Journal of Psychiatry. appiajp202019030331. PMID 32539527 DOI: 10.1176/Appi.Ajp.2020.19030331 |
0.645 |
|
| 2020 |
Mutsaerts HJMM, Petr J, Groot P, Vandemaele P, Ingala S, Robertson AD, Václavů L, Groote I, Kuijf H, Zelaya F, O'Daly O, Hilal S, Wink AM, Kant I, Caan MWA, ... ... Reneman L, et al. ExploreASL: an image processing pipeline for multi-center ASL perfusion MRI studies. Neuroimage. 117031. PMID 32526385 DOI: 10.1016/J.Neuroimage.2020.117031 |
0.628 |
|
| 2020 |
Schmaal L, Pozzi E, C Ho T, van Velzen LS, Veer IM, Opel N, Van Someren EJW, Han LKM, Aftanas L, Aleman A, Baune BT, Berger K, Blanken TF, Capitão L, Couvy-Duchesne B, ... ... Reneman L, et al. ENIGMA MDD: seven years of global neuroimaging studies of major depression through worldwide data sharing. Translational Psychiatry. 10: 172. PMID 32472038 DOI: 10.1038/S41398-020-0842-6 |
0.705 |
|
| 2020 |
Opel N, Thalamuthu A, Milaneschi Y, Grotegerd D, Flint C, Leenings R, Goltermann J, Richter M, Hahn T, Woditsch G, Berger K, Hermesdorf M, McIntosh A, Whalley HC, Harris MA, ... ... Reneman L, et al. Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders : Evidence through univariate and multivariate mega-analysis including 6420 participants from the ENIGMA MDD working group. Molecular Psychiatry. PMID 32467648 DOI: 10.1038/S41380-020-0774-9 |
0.688 |
|
| 2020 |
Han LKM, Dinga R, Hahn T, Ching CRK, Eyler LT, Aftanas L, Aghajani M, Aleman A, Baune BT, Berger K, Brak I, Filho GB, Carballedo A, Connolly CG, Couvy-Duchesne B, ... ... Reneman L, et al. Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group. Molecular Psychiatry. PMID 32424236 DOI: 10.1038/S41380-020-0754-0 |
0.715 |
|
| 2020 |
Hoogman M, van Rooij D, Klein M, Boedhoe P, Ilioska I, Li T, Patel Y, Postema MC, Zhang-James Y, Anagnostou E, Arango C, Auzias G, Banaschewski T, Bau CHD, Behrmann M, ... ... Reneman L, et al. Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure. Human Brain Mapping. PMID 32420680 DOI: 10.1002/Hbm.25029 |
0.345 |
|
| 2020 |
Walhovd KB, Amlien I, Schrantee A, Rohani DA, Groote I, Bjørnerud A, Fjell AM, Reneman L. Methylphenidate Effects on Cortical Thickness in Children and Adults with Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. Ajnr. American Journal of Neuroradiology. 41: 758-765. PMID 32414901 DOI: 10.3174/Ajnr.A6560 |
0.664 |
|
| 2020 |
Solleveld MM, Schrantee A, Baek HK, Bottelier MA, Tamminga HGH, Bouziane C, Stoffelsen R, Lucassen PJ, Van Someren EJW, Rijsman RM, Reneman L. Effects of 16 Weeks of Methylphenidate Treatment on Actigraph-Assessed Sleep Measures in Medication-Naive Children With ADHD. Frontiers in Psychiatry. 11: 82. PMID 32184743 DOI: 10.3389/Fpsyt.2020.00082 |
0.775 |
|
| 2020 |
Schrantee A, Ruhé HG, Reneman L. Psychoradiological Biomarkers for Psychopharmaceutical Effects. Neuroimaging Clinics of North America. 30: 53-63. PMID 31759572 DOI: 10.1016/J.Nic.2019.09.006 |
0.612 |
|
| 2020 |
Kaiser A, Reneman L, Lucassen P, Kaag A, Van der Zwaag W, Jurhar T, Kirschbaum C, Van den Heuvel O, Hermans E, Tan H. P.192 The association between stress-induced changes in prefrontal GABA levels and heart rate variability: a 7T 1H-MRS study European Neuropsychopharmacology. 40: S111-S112. DOI: 10.1016/j.euroneuro.2020.09.147 |
0.764 |
|
| 2020 |
Maletic-Savatic M, Li Y, Young D, Elvsåshagen T, Loo C, Reneman L, Lucassen PJ, Calarge C, Valenzuela M. Fatty Acids as Biomarkers of Neurogenesis and New Targets for Treatment of Depression Biological Psychiatry. 87: S59. DOI: 10.1016/J.Biopsych.2020.02.174 |
0.474 |
|
| 2020 |
Schrantee A, Kaiser A, Lindauer R, Bottelier M, Reneman L. The Association Between Medication, Dopamine Function, and Long-Term Symptom Severity in the Matured and Developing Brain in ADHD Biological Psychiatry. 87: S18-S19. DOI: 10.1016/J.Biopsych.2020.02.073 |
0.787 |
|
| 2019 |
Chye Y, Mackey S, Gutman BA, Ching CRK, Batalla A, Blaine S, Brooks S, Caparelli EC, Cousijn J, Dagher A, Foxe JJ, Goudriaan AE, Hester R, Hutchison K, Jahanshad N, ... ... Reneman L, et al. Subcortical surface morphometry in substance dependence: An ENIGMA addiction working group study. Addiction Biology. e12830. PMID 31746534 DOI: 10.1111/Adb.12830 |
0.756 |
|
| 2019 |
Bouziane C, Filatova OG, Schrantee A, Caan MWA, Vos FM, Reneman L. White Matter by Diffusion MRI Following Methylphenidate Treatment: A Randomized Control Trial in Males with Attention-Deficit/Hyperactivity Disorder. Radiology. 182528. PMID 31407970 DOI: 10.1148/Radiol.2019182528 |
0.814 |
|
| 2019 |
de Kovel CGF, Aftanas L, Aleman A, Alexander-Bloch AF, Baune BT, Brack I, Bülow R, Busatto Filho G, Carballedo A, Connolly CG, Cullen KR, Dannlowski U, Davey CG, Dima D, Dohm K, ... ... Reneman L, et al. No Alterations of Brain Structural Asymmetry in Major Depressive Disorder: An ENIGMA Consortium Analysis. The American Journal of Psychiatry. appiajp201918101144. PMID 31352813 DOI: 10.1176/Appi.Ajp.2019.18101144 |
0.709 |
|
| 2019 |
Vingerhoets C, Bakker G, Schrantee A, van der Pluijm M, Bloemen OJN, Reneman L, Caan M, Booij J, van Amelsvoort TAMJ. Influence of muscarinic M receptor antagonism on brain choline levels and functional connectivity in medication-free subjects with psychosis: A placebo controlled, cross-over study. Psychiatry Research. Neuroimaging. 290: 5-13. PMID 31252222 DOI: 10.1016/J.Pscychresns.2019.06.005 |
0.721 |
|
| 2019 |
Hoogman M, Muetzel R, Guimaraes JP, Shumskaya E, Mennes M, Zwiers MP, Jahanshad N, Sudre G, Wolfers T, Earl EA, Soliva Vila JC, Vives-Gilabert Y, Khadka S, Novotny SE, Hartman CA, ... ... Reneman L, et al. Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples. The American Journal of Psychiatry. appiajp201918091033. PMID 31014101 DOI: 10.1176/Appi.Ajp.2019.18091033 |
0.659 |
|
| 2019 |
Schrantee A, Solleveld MM, Schwantje H, Bruin WB, Mutsaerts HM, Adriaanse SM, Lucassen P, Booij J, Reneman L. Dose-dependent effects of the selective serotonin reuptake inhibitor citalopram: A combined SPECT and phMRI study. Journal of Psychopharmacology (Oxford, England). 269881119836229. PMID 30887865 DOI: 10.1177/0269881119836229 |
0.749 |
|
| 2019 |
Karel P, Van der Toorn A, Vanderschuren L, Guo C, Sadighi Alvandi M, Reneman L, Dijkhuizen R, Verheij MMM, Homberg JR. Ultrahigh-resolution MRI reveals structural brain differences in serotonin transporter knockout rats after sucrose and cocaine self-administration. Addiction Biology. PMID 30748070 DOI: 10.1111/Adb.12722 |
0.313 |
|
| 2019 |
Kaiser A, Reneman L, Lucassen P, De Vries T, Kaag A, Schrantee A. P.3.07 Targeting emotional dysregulation in adult attention-deficit hyperactivity disorder European Neuropsychopharmacology. 29: S683-S684. DOI: 10.1016/J.Euroneuro.2019.01.069 |
0.778 |
|
| 2018 |
Schrantee A, Lucassen PJ, Booij J, Reneman L. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30082141 DOI: 10.1016/J.Euroneuro.2018.07.099 |
0.769 |
|
| 2018 |
Stouten-Kemperman MM, de Ruiter MB, Boogerd W, Kerst JM, Kirschbaum C, Reneman L, Schagen SB. Brain hyperconnectivity >10 years after cisplatin based chemotherapy for testicular cancer. Brain Connectivity. PMID 29999422 DOI: 10.1089/Brain.2017.0569 |
0.773 |
|
| 2018 |
Kaag AM, Schulte MHJ, Jansen JM, van Wingen G, Homberg J, van den Brink W, Wiers RW, Schmaal L, Goudriaan AE, Reneman L. The relation between gray matter volume and the use of alcohol, tobacco, cocaine and cannabis in male polysubstance users. Drug and Alcohol Dependence. 187: 186-194. PMID 29679913 DOI: 10.1016/J.Drugalcdep.2018.03.010 |
0.465 |
|
| 2018 |
Kaag AM, Reneman L, Homberg J, van den Brink W, van Wingen GA. Enhanced Amygdala-Striatal Functional Connectivity during the Processing of Cocaine Cues in Male Cocaine Users with a History of Childhood Trauma. Frontiers in Psychiatry. 9: 70. PMID 29593581 DOI: 10.3389/Fpsyt.2018.00070 |
0.742 |
|
| 2018 |
Bouziane C, Caan MWA, Tamminga HGH, Schrantee A, Bottelier MA, de Ruiter MB, Kooij SJJ, Reneman L. ADHD and maturation of brain white matter: A DTI study in medication naive children and adults. Neuroimage. Clinical. 17: 53-59. PMID 29527472 DOI: 10.1016/J.Nicl.2017.09.026 |
0.794 |
|
| 2018 |
Karel P, Almacellas-Barbanoj A, Prijn J, Kaag AM, Reneman L, Verheij MMM, Homberg JR. Appetitive to aversive counter-conditioning as intervention to reduce reinstatement of reward-seeking behavior: the role of the serotonin transporter. Addiction Biology. PMID 29292566 DOI: 10.1111/Adb.12596 |
0.706 |
|
| 2018 |
Vingerhoets C, Bakker G, Pluijm Mvd, Bloemen O, Reneman L, Caan M, Booij J, Amelsvoort Tv. S172. BRAIN METABOLITES AND THE RELATION WITH COGNITION AND PSYCHOTIC SYMPTOMS IN MEDICATION-FREE PSYCHOSIS AND CONTROLS: A PHARMACOLOGICAL MAGNETIC RESONANCE SPECTROSCOPY STUDY Schizophrenia Bulletin. 44: S391-S392. DOI: 10.1016/J.Biopsych.2018.02.833 |
0.517 |
|
| 2018 |
Schrantee A, Wijnen JP, Solleveld MM, Nederveen AJ, Dumoulin S, Klomp DW, Reneman L, Lucassen PJ. F153. The Effect of a 12-Week Aerobic Exercise Intervention on Neurometabolites in Young Healthy Adults Using 7T Magnetic Resonance Spectroscopy Biological Psychiatry. 83: S297-S298. DOI: 10.1016/J.Biopsych.2018.02.767 |
0.683 |
|
| 2018 |
Schrantee A, Lucassen PJ, Reneman L, Booij J. T138. Serotonin Transporter Occupancy Predicts Default-Mode Network Connectivity: A SPECT and Resting-State fMRI Study Biological Psychiatry. 83: S182. DOI: 10.1016/J.Biopsych.2018.02.475 |
0.727 |
|
| 2017 |
Mugie SM, Koppen IJN, van den Berg MM, Groot PFC, Reneman L, de Ruiter MB, Benninga MA. Brain processing of rectal sensation in adolescents with functional defecation disorders and healthy controls. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. PMID 28975729 DOI: 10.1111/Nmo.13228 |
0.757 |
|
| 2017 |
Bottelier MA, Schrantee A, Ferguson B, Tamminga HGH, Bouziane C, Kooij JJS, de Ruiter MB, Reneman L. Age-dependent effects of acute methylphenidate on amygdala reactivity in stimulant treatment-naive patients with Attention Deficit/Hyperactivity Disorder. Psychiatry Research. 269: 36-42. PMID 28938219 DOI: 10.1016/J.Pscychresns.2017.09.009 |
0.798 |
|
| 2017 |
Schulte MHJ, Kaag AM, Wiers RW, Schmaal L, van den Brink W, Reneman L, Homberg JR, van Wingen GA, Goudriaan AE. Prefrontal Glx and GABA concentrations and impulsivity in cigarette smokers and smoking polysubstance users. Drug and Alcohol Dependence. 179: 117-123. PMID 28763779 DOI: 10.1016/J.Drugalcdep.2017.06.025 |
0.737 |
|
| 2017 |
Solleveld MM, Schrantee A, Puts NAJ, Reneman L, Lucassen PJ. Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients. Neuroimage. Clinical. 15: 812-818. PMID 28725548 DOI: 10.1016/J.Nicl.2017.06.003 |
0.731 |
|
| 2017 |
Versteeg RI, Schrantee A, Adriaanse SM, Unmehopa UA, Booij J, Reneman L, Fliers E, la Fleur SE, Serlie MJ. Timing of caloric intake during weight loss differentially affects striatal dopamine transporter and thalamic serotonin transporter binding. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 28679529 DOI: 10.1096/Fj.201601234R |
0.687 |
|
| 2017 |
Schrantee A, Václavů L, Reneman L, Verberne HJ, Booij J, Tan HL. QT prolongation by dexamphetamine: Does experience matter? Journal of Cardiovascular Electrophysiology. PMID 28452189 DOI: 10.1111/Jce.13235 |
0.699 |
|
| 2017 |
Schrantee A, Bouziane C, Bron EE, Klein S, Bottelier MA, Kooij JJ, Rombouts SA, Reneman L. Long-term effects of stimulant exposure on cerebral blood flow response to methylphenidate and behavior in attention-deficit hyperactivity disorder. Brain Imaging and Behavior. PMID 28321605 DOI: 10.1007/S11682-017-9707-X |
0.81 |
|
| 2017 |
Menning S, de Ruiter MB, Veltman DJ, Boogerd W, Oldenburg HS, Reneman L, Schagen SB. Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study. Brain Imaging and Behavior. PMID 28290072 DOI: 10.1007/S11682-017-9695-X |
0.783 |
|
| 2017 |
Menning S, de Ruiter MB, Veltman DJ, Boogerd W, Oldenburg HS, Reneman L, Schagen SB. Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type. Plos One. 12: e0171724. PMID 28267750 DOI: 10.1371/Journal.Pone.0171724 |
0.781 |
|
| 2017 |
Schrantee A, Tremoleda JL, Wylezinska-Arridge M, Bouet V, Hesseling P, Meerhoff GF, de Bruin KM, Koeleman J, Freret T, Boulouard M, Desfosses E, Galineau L, Gozzi A, Dauphin F, Gsell W, ... ... Reneman L, et al. Repeated dexamphetamine treatment alters the dopaminergic system and increases the phMRI response to methylphenidate. Plos One. 12: e0172776. PMID 28241065 DOI: 10.1371/Journal.Pone.0172776 |
0.77 |
|
| 2017 |
Schrantee A, Mutsaerts H, Bouziane C, Tamminga H, Bottelier MA, Reneman L. The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder. Neuroimage. Clinical. 13: 123-129. PMID 27942455 DOI: 10.1016/J.Nicl.2016.11.021 |
0.806 |
|
| 2017 |
Solleveld M, Schrantee A, Baek H, Bottelier M, Lucassen P, Van Someren E, Rijsman R, Reneman L. Enduring effects of methylphenidate on sleep in children with attention-deficit/hyperactivity disorder: a double-blind randomized controlled trial European Neuropsychopharmacology. 27: S1111-S1112. DOI: 10.1016/S0924-977X(17)31927-2 |
0.702 |
|
| 2017 |
Kaiser A, Schrantee A, Solleveld M, Reneman L, Lucassen P. Effects of cardiovascular fitness on hippocampal volume and vasculature in young adults European Neuropsychopharmacology. 27: S720-S721. DOI: 10.1016/S0924-977X(17)31327-5 |
0.765 |
|
| 2017 |
Schrantee A, Lucassen P, Booij J, Reneman L. Non-invasive magnetic resonance imaging of human serotonin function: dose-dependent effects of citalopram European Neuropsychopharmacology. 27: S707-S708. DOI: 10.1016/S0924-977X(17)31308-1 |
0.747 |
|
| 2016 |
Menning S, de Ruiter MB, Kieffer JM, van Rentergem JA, Veltman DJ, Fruijtier A, Oldenburg HS, Boven E, van der Meij S, Lustig V, Bos ME, Boogerd W, Reneman L, Schagen SB. Cognitive impairment in a subset of breast cancer patients following systemic therapy - results from a longitudinal study. Journal of Pain and Symptom Management. PMID 27650011 DOI: 10.1016/J.Jpainsymman.2016.04.012 |
0.766 |
|
| 2016 |
Kaag AM, Schluter RS, Karel P, Homberg J, van den Brink W, Reneman L, van Wingen GA. Aversive Counterconditioning Attenuates Reward Signaling in the Ventral Striatum. Frontiers in Human Neuroscience. 10: 418. PMID 27594829 DOI: 10.3389/Fnhum.2016.00418 |
0.738 |
|
| 2016 |
Vegting Y, Reneman L, Booij J. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies. Psychopharmacology. PMID 27568200 DOI: 10.1007/S00213-016-4396-5 |
0.5 |
|
| 2016 |
Schrantee A, Tamminga HG, Bouziane C, Bottelier MA, Bron EE, Mutsaerts HM, Zwinderman AH, Groote IR, Rombouts SA, Lindauer RJ, Klein S, Niessen WJ, Opmeer BC, Boer F, Lucassen PJ, ... ... Reneman L, et al. Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 27487479 DOI: 10.1001/Jamapsychiatry.2016.1572 |
0.795 |
|
| 2016 |
van de Vijver I, Ridderinkhof KR, Harsay H, Reneman L, Cavanagh JF, Buitenweg JI, Cohen MX. Frontostriatal anatomical connections predict age- and difficulty-related differences in reinforcement learning. Neurobiology of Aging. 46: 1-12. PMID 27460144 DOI: 10.1016/J.Neurobiolaging.2016.06.002 |
0.304 |
|
| 2016 |
Kaag AM, Levar N, Woutersen K, Homberg J, van den Brink W, Reneman L, van Wingen G. Hyperresponsiveness of the Neural Fear Network During Fear Conditioning and Extinction Learning in Male Cocaine Users. The American Journal of Psychiatry. appiajp201615040433. PMID 27079132 DOI: 10.1176/Appi.Ajp.2016.15040433 |
0.736 |
|
| 2016 |
Tamminga HG, Reneman L, Huizenga HM, Geurts HM. Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis. Psychological Medicine. 1-17. PMID 27019103 DOI: 10.1017/S0033291716000350 |
0.35 |
|
| 2016 |
Kaag AM, van Wingen GA, Caan MW, Homberg JR, van den Brink W, Reneman L. White matter alterations in cocaine users are negatively related to the number of additionally (ab)used substances. Addiction Biology. PMID 26860848 DOI: 10.1111/Adb.12375 |
0.755 |
|
| 2016 |
Bottelier MA, Schrantee A, van Wingen G, Ruhé HG, de Ruiter MB, Reneman L. A power analysis for future clinical trials on the potential adverse effects of SSRIs on amygdala reactivity Frontiers in Biology. 11: 256-259. DOI: 10.1007/S11515-016-1402-6 |
0.646 |
|
| 2015 |
van Doorn M, Oude Rengerink K, Newsum EA, Reneman L, Majoie CB, Pajkrt E. Added value of fetal MRI in fetuses with suspected brain abnormalities on neurosonography: a systematic review and meta-analysis. The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 1-13. PMID 26592136 DOI: 10.3109/14767058.2015.1109621 |
0.304 |
|
| 2015 |
Stouten-Kemperman MM, de Ruiter MB, Caan MW, Boogerd W, Kerst MJ, Reneman L, Schagen SB. Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy. Human Brain Mapping. PMID 26304182 DOI: 10.1002/Hbm.22942 |
0.758 |
|
| 2015 |
Klomp A, Václavů L, Meerhoff GF, Reneman L, Lucassen PJ. Correction: Effects of Chronic Fluoxetine Treatment on Neurogenesis and Tryptophan Hydroxylase Expression in Adolescent and Adult Rats. Plos One. 10: e0135876. PMID 26295703 DOI: 10.1371/journal.pone.0135876 |
0.706 |
|
| 2015 |
Crunelle CL, Kaag AM, van den Munkhof HE, Reneman L, Homberg JR, Sabbe B, van den Brink W, van Wingen G. Dysfunctional amygdala activation and connectivity with the prefrontal cortex in current cocaine users. Human Brain Mapping. 36: 4222-30. PMID 26220024 DOI: 10.1002/Hbm.22913 |
0.745 |
|
| 2015 |
Schrantee A, Ferguson B, Stoffers D, Booij J, Rombouts S, Reneman L. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls. Brain Imaging and Behavior. PMID 26149196 DOI: 10.1007/S11682-015-9419-Z |
0.721 |
|
| 2015 |
Reneman L, Schagen SB, Mulder M, Mutsaerts HJ, Hageman G, de Ruiter MB. Cognitive impairment and associated loss in brain white microstructure in aircrew members exposed to engine oil fumes. Brain Imaging and Behavior. PMID 26063438 DOI: 10.1007/S11682-015-9395-3 |
0.77 |
|
| 2015 |
van der Marel K, Bouet V, Meerhoff GF, Freret T, Boulouard M, Dauphin F, Klomp A, Lucassen PJ, Homberg JR, Dijkhuizen RM, Reneman L. Effects of long-term methylphenidate treatment in adolescent and adult rats on hippocampal shape, functional connectivity and adult neurogenesis. Neuroscience. PMID 25934041 DOI: 10.1016/J.Neuroscience.2015.04.044 |
0.759 |
|
| 2015 |
Menning S, de Ruiter MB, Veltman DJ, Koppelmans V, Kirschbaum C, Boogerd W, Reneman L, Schagen SB. Multimodal MRI and cognitive function in patients with breast cancer prior to adjuvant treatment--the role of fatigue. Neuroimage. Clinical. 7: 547-54. PMID 25844311 DOI: 10.1016/J.Nicl.2015.02.005 |
0.791 |
|
| 2015 |
Bottelier MA, Schouw ML, de Ruiter MB, Ruhe HG, Lindauer RJ, Reneman L. Effects of methylphenidate during emotional processing in amphetamine users: preliminary findings. Brain Imaging and Behavior. PMID 25563230 DOI: 10.1007/S11682-014-9350-8 |
0.796 |
|
| 2015 |
Schrantee A, Václav? L, Heijtel DF, Caan MW, Gsell W, Lucassen PJ, Nederveen AJ, Booij J, Reneman L. Dopaminergic system dysfunction in recreational dexamphetamine users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1172-80. PMID 25394786 DOI: 10.1038/Npp.2014.301 |
0.778 |
|
| 2015 |
Stouten-Kemperman MM, de Ruiter MB, Koppelmans V, Boogerd W, Reneman L, Schagen SB. Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type. Brain Imaging and Behavior. 9: 275-84. PMID 24858488 DOI: 10.1007/S11682-014-9305-0 |
0.786 |
|
| 2015 |
Schrantee A, Mutsaerts H, Tamminga G, Bouziane C, Bottelier M, Rombouts S, Reneman L. P.1.i.044 The effects of methylphenidate on striatal dopamine system are dependent on age: a pharmacological magnetic resonance imaging study European Neuropsychopharmacology. 25: S326-S327. DOI: 10.1016/S0924-977X(15)30403-X |
0.784 |
|
| 2015 |
Solleveld M, Schrantee A, Bouziane C, Ruhé H, Reneman L. P.1.i.043 Age-dependent effects of selective serotonin reuptake inhibitor exposure on the development of the GABA-ergic system European Neuropsychopharmacology. 25: S325-S326. DOI: 10.1016/S0924-977X(15)30402-8 |
0.768 |
|
| 2015 |
Kaag A, Levar N, Woutersen K, Homberg J, Van den Brink W, Reneman L, Van Wingen G. S.15.03 Hyperresponsiveness of the neural fear network in cocaine abuse disorder European Neuropsychopharmacology. 25: S134. DOI: 10.1016/S0924-977X(15)30078-X |
0.695 |
|
| 2015 |
Koppen IJ, Mugie SM, van den Berg MM, Groot P, de Ruiter MB, Reneman L, Nederveen A, Benninga MA. Su2064 Brain Processing of Rectal Sensation in Children With Functional Defecation Disorders Gastroenterology. 148: S-588. DOI: 10.1016/S0016-5085(15)31993-4 |
0.31 |
|
| 2015 |
Schrantee A, Ferguson B, Stoffers D, Booij J, Rombouts S, Reneman L. Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls Brain Imaging and Behavior. DOI: 10.1007/s11682-015-9419-z |
0.668 |
|
| 2015 |
Reneman L, Schagen SB, Mulder M, Mutsaerts HJ, Hageman G, de Ruiter MB. Cognitive impairment and associated loss in brain white microstructure in aircrew members exposed to engine oil fumes Brain Imaging and Behavior. DOI: 10.1007/s11682-015-9395-3 |
0.726 |
|
| 2014 |
Stouten-Kemperman MM, de Ruiter MB, Boogerd W, Veltman DJ, Reneman L, Schagen SB. Very Late Treatment-Related Alterations in Brain Function of Breast Cancer Survivors. Journal of the International Neuropsychological Society : Jins. 1-12. PMID 25529014 DOI: 10.1017/S1355617714001015 |
0.786 |
|
| 2014 |
Kaag AM, Crunelle CL, van Wingen G, Homberg J, van den Brink W, Reneman L. Relationship between trait impulsivity and cortical volume, thickness and surface area in male cocaine users and non-drug using controls. Drug and Alcohol Dependence. 144: 210-7. PMID 25278147 DOI: 10.1016/J.Drugalcdep.2014.09.016 |
0.745 |
|
| 2014 |
Klomp A, Hamelink R, Feenstra M, Denys D, Reneman L. Increased response to a 5-HT challenge after discontinuation of chronic serotonin uptake inhibition in the adult and adolescent rat brain. Plos One. 9: e99873. PMID 24937739 DOI: 10.1371/Journal.Pone.0099873 |
0.697 |
|
| 2014 |
Klomp A, Václav? L, Meerhoff GF, Reneman L, Lucassen PJ. Effects of chronic fluoxetine treatment on neurogenesis and tryptophan hydroxylase expression in adolescent and adult rats. Plos One. 9: e97603. PMID 24827731 DOI: 10.1371/Journal.Pone.0097603 |
0.746 |
|
| 2014 |
Bottelier MA, Schouw ML, Klomp A, Tamminga HG, Schrantee AG, Bouziane C, de Ruiter MB, Boer F, Ruhé HG, Denys D, Rijsman R, Lindauer RJ, Reitsma HB, Geurts HM, Reneman L. The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design. Bmc Psychiatry. 14: 48. PMID 24552282 DOI: 10.1186/1471-244X-14-48 |
0.789 |
|
| 2014 |
Crunelle CL, Kaag AM, van Wingen G, van den Munkhof HE, Homberg JR, Reneman L, van den Brink W. Reduced frontal brain volume in non-treatment-seeking cocaine-dependent individuals: exploring the role of impulsivity, depression, and smoking. Frontiers in Human Neuroscience. 8: 7. PMID 24478673 DOI: 10.3389/Fnhum.2014.00007 |
0.746 |
|
| 2014 |
van der Marel K, Klomp A, Meerhoff GF, Schipper P, Lucassen PJ, Homberg JR, Dijkhuizen RM, Reneman L. Long-term oral methylphenidate treatment in adolescent and adult rats: differential effects on brain morphology and function. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 263-73. PMID 23851400 DOI: 10.1038/Npp.2013.169 |
0.774 |
|
| 2014 |
Schrantee A, Reneman L. Pharmacological imaging as a tool to visualise dopaminergic neurotoxicity. Neuropharmacology. 84: 159-69. PMID 23851258 DOI: 10.1016/J.Neuropharm.2013.06.029 |
0.65 |
|
| 2014 |
Ferguson B, Schrantee A, De Ruiter M, Bottelier M, Reneman L. P.7.e.001 Opposite effects of acute methylphenidate administration in children versus adult ADHD patients during emotional processing European Neuropsychopharmacology. 24: S728-S729. DOI: 10.1016/S0924-977X(14)71173-3 |
0.633 |
|
| 2014 |
Tamminga H, Reneman L, Huizenga H, Geurts H. P.7.d.012 Effects of methylphenidate on cognition in ADHD across the lifespan: preliminary results of a meta-regression analysis European Neuropsychopharmacology. 24: S727. DOI: 10.1016/S0924-977X(14)71171-X |
0.36 |
|
| 2014 |
Schrantee A, Ferguson B, Stoffers D, Reneman L. P.1.i.028 Effects of dexamphetamine on fronto–striatal network connectivity in recreational users European Neuropsychopharmacology. 24: S313-S314. DOI: 10.1016/S0924-977X(14)70497-3 |
0.608 |
|
| 2014 |
Mugie SM, van den Berg MM, Groot P, de Ruiter MB, Reneman L, Nederveen A, Benninga MA. 242 Brain Processing of Rectal Sensation in Children With Chronic Functional Constipation Gastroenterology. 146: S-58. DOI: 10.1016/S0016-5085(14)60201-8 |
0.364 |
|
| 2013 |
Klomp A, van Wingen GA, de Ruiter MB, Caan MW, Denys D, Reneman L. Test-retest reliability of task-related pharmacological MRI with a single-dose oral citalopram challenge. Neuroimage. 75: 108-16. PMID 23501048 DOI: 10.1016/J.Neuroimage.2013.03.002 |
0.795 |
|
| 2013 |
Schouw ML, Caan MW, Geurts HM, Schmand B, Booij J, Nederveen AJ, Reneman L. Monoaminergic dysfunction in recreational users of dexamphetamine. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1491-502. PMID 23415394 DOI: 10.1016/J.Euroneuro.2013.01.005 |
0.805 |
|
| 2013 |
Schouw ML, Kaag AM, Caan MW, Heijtel DF, Majoie CB, Nederveen AJ, Booij J, Reneman L. Mapping the hemodynamic response in human subjects to a dopaminergic challenge with dextroamphetamine using ASL-based pharmacological MRI. Neuroimage. 72: 1-9. PMID 23296186 DOI: 10.1016/J.Neuroimage.2012.12.056 |
0.783 |
|
| 2013 |
Booij J, Reneman L, Alders M, Kuijpers TW. Increase in central striatal dopamine transporters in patients with Shwachman-Diamond syndrome: additional evidence of a brain phenotype. American Journal of Medical Genetics. Part A. 161: 102-7. PMID 23239620 DOI: 10.1002/Ajmg.A.35687 |
0.572 |
|
| 2013 |
Schouw ML, De Ruiter MB, Kaag AM, van den Brink W, Lindauer RJ, Reneman L. Dopaminergic dysfunction in abstinent dexamphetamine users: results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge. Drug and Alcohol Dependence. 130: 52-60. PMID 23142493 DOI: 10.1016/J.Drugalcdep.2012.10.010 |
0.796 |
|
| 2013 |
Kaag A, Crunelle C, Van den Brink W, Homberg J, Reneman L. P.6.d.005 Differential effects of short- and long-term cocaine use on cortical volume, thickness and surface area European Neuropsychopharmacology. 23: S576. DOI: 10.1016/S0924-977X(13)70917-9 |
0.707 |
|
| 2013 |
Schrantee A, Tremoleda J, Wylezinska-Arridge M, Gsell W, Reneman L. P.1.i.016 Amphetamine pretreatment alters the response to a methylphenidate challenge: a pharmacological magnetic resonance imaging study European Neuropsychopharmacology. 23: S272. DOI: 10.1016/S0924-977X(13)70424-3 |
0.625 |
|
| 2012 |
Klomp A, den Hollander B, de Bruin K, Booij J, Reneman L. The effects of ecstasy (MDMA) on brain serotonin transporters are dependent on age-of-first exposure in recreational users and animals. Plos One. 7: e47524. PMID 23115651 DOI: 10.1371/Journal.Pone.0047524 |
0.749 |
|
| 2012 |
Klomp A, Caan MW, Denys D, Nederveen AJ, Reneman L. Feasibility of ASL-based phMRI with a single dose of oral citalopram for repeated assessment of serotonin function. Neuroimage. 63: 1695-700. PMID 22842212 DOI: 10.1016/J.Neuroimage.2012.07.038 |
0.696 |
|
| 2012 |
Reneman L, de Win MM, Booij J, van den Brink W, den Heeten GJ, Freling N, Majoie CB. Incidental head and neck findings on MRI in young healthy volunteers: prevalence and clinical implications. Ajnr. American Journal of Neuroradiology. 33: 1971-4. PMID 22723061 DOI: 10.3174/Ajnr.A3217 |
0.716 |
|
| 2012 |
Klomp A, Tremoleda JL, Schrantee A, Gsell W, Reneman L. The use of pharmacological-challenge fMRI in pre-clinical research: application to the 5-HT system. Journal of Visualized Experiments : Jove. PMID 22565099 DOI: 10.3791/3956 |
0.792 |
|
| 2012 |
Schouw ML, Gevers S, Caan MW, Majoie CB, Booij J, Nederveen AJ, Reneman L. Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 537-45. PMID 22209360 DOI: 10.1016/J.Euroneuro.2011.12.002 |
0.799 |
|
| 2012 |
Bouet V, Klomp A, Freret T, Wylezinska-Arridge M, Lopez-Tremoleda J, Dauphin F, Boulouard M, Booij J, Gsell W, Reneman L. Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment. Psychopharmacology. 221: 329-39. PMID 22205158 DOI: 10.1007/S00213-011-2580-1 |
0.764 |
|
| 2012 |
de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, Caan M, Douaud G, Lavini C, Linn SC, Boven E, van Dam FS, Schagen SB. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Human Brain Mapping. 33: 2971-83. PMID 22095746 DOI: 10.1002/Hbm.21422 |
0.795 |
|
| 2012 |
Klomp A, Tremoleda JL, Wylezinska M, Nederveen AJ, Feenstra M, Gsell W, Reneman L. Lasting effects of chronic fluoxetine treatment on the late developing rat brain: age-dependent changes in the serotonergic neurotransmitter system assessed by pharmacological MRI. Neuroimage. 59: 218-26. PMID 21840402 DOI: 10.1016/J.Neuroimage.2011.07.082 |
0.725 |
|
| 2012 |
den Hollander B, Schouw M, Groot P, Huisman H, Caan M, Barkhof F, Reneman L. Preliminary evidence of hippocampal damage in chronic users of ecstasy. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 83-5. PMID 21444322 DOI: 10.1136/Jnnp.2010.228387 |
0.789 |
|
| 2011 |
Harsay HA, Cohen MX, Reneman L, Ridderinkhof KR. How the aging brain translates motivational incentive into action: the role of individual differences in striato-cortical white matter pathways. Developmental Cognitive Neuroscience. 1: 530-9. PMID 22436569 DOI: 10.1016/J.Dcn.2011.06.005 |
0.327 |
|
| 2011 |
Homberg JR, Olivier JD, Blom T, Arentsen T, van Brunschot C, Schipper P, Korte-Bouws G, van Luijtelaar G, Reneman L. Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. Plos One. 6: e16646. PMID 21304948 DOI: 10.1371/Journal.Pone.0016646 |
0.323 |
|
| 2011 |
de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, van Dam FS, Nederveen AJ, Boven E, Schagen SB. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping. 32: 1206-19. PMID 20669165 DOI: 10.1002/Hbm.21102 |
0.793 |
|
| 2008 |
de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, den Heeten GJ, van den Brink W. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users. Brain : a Journal of Neurology. 131: 2936-45. PMID 18842607 DOI: 10.1093/Brain/Awn255 |
0.742 |
|
| 2008 |
de Win MM, Jager G, Booij J, Reneman L, Schilt T, Lavini C, Olabarriaga SD, Ramsey NF, Heeten GJ, van den Brink W. Neurotoxic effects of ecstasy on the thalamus. The British Journal of Psychiatry : the Journal of Mental Science. 193: 289-96. PMID 18827290 DOI: 10.1192/Bjp.Bp.106.035089 |
0.614 |
|
| 2008 |
Visser I, Lavini C, Booij J, Reneman L, Majoie C, de Boer AG, Wekking EM, de Joode EA, van der Laan G, van Dijk FJ, Schene AH, Den Heeten GJ. Cerebral impairment in chronic solvent-induced encephalopathy. Annals of Neurology. 63: 572-80. PMID 18412121 DOI: 10.1002/Ana.21364 |
0.667 |
|
| 2007 |
de Win MM, Reneman L, Jager G, Vlieger EJ, Olabarriaga SD, Lavini C, Bisschops I, Majoie CB, Booij J, den Heeten GJ, van den Brink W. A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 458-70. PMID 17077812 DOI: 10.1038/Sj.Npp.1301225 |
0.742 |
|
| 2006 |
Reneman L, Schilt T, de Win MM, Booij J, Schmand B, van den Brink W, Bakker O. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. Journal of Psychopharmacology (Oxford, England). 20: 389-99. PMID 16574713 DOI: 10.1177/0269881106063266 |
0.624 |
|
| 2006 |
de Win MM, Schilt T, Reneman L, Vervaeke H, Jager G, Dijkink S, Booij J, van den Brink W. Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study. Journal of Psychopharmacology (Oxford, England). 20: 226-35. PMID 16510480 DOI: 10.1177/0269881106063275 |
0.575 |
|
| 2006 |
Reneman L, de Win MM, van den Brink W, Booij J, den Heeten GJ. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects. Journal of Psychopharmacology (Oxford, England). 20: 164-75. PMID 16510475 DOI: 10.1177/0269881106061515 |
0.731 |
|
| 2005 |
De Win MM, Jager G, Vervaeke HK, Schilt T, Reneman L, Booij J, Verhulst FC, Den Heeten GJ, Ramsey NF, Korf DJ, Van den Brink W. The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. International Journal of Methods in Psychiatric Research. 14: 167-85. PMID 16395871 DOI: 10.1002/Mpr.6 |
0.753 |
|
| 2005 |
de Win MM, Habraken JB, Reneman L, van den Brink W, den Heeten GJ, Booij J. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 996-1005. PMID 15770240 DOI: 10.1038/Sj.Npp.1300683 |
0.711 |
|
| 2004 |
de Win MM, de Jeu RA, de Bruin K, Habraken JB, Reneman L, Booij J, den Heeten GJ. Validity of in vivo [123I]beta-CIT SPECT in detecting MDMA-induced neurotoxicity in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 185-9. PMID 15056477 DOI: 10.1016/S0924-977X(03)00101-9 |
0.666 |
|
| 2004 |
de Win MM, Reneman L, Reitsma JB, den Heeten GJ, Booij J, van den Brink W. Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender. Psychopharmacology. 173: 376-82. PMID 14726997 DOI: 10.1007/S00213-003-1723-4 |
0.721 |
|
| 2002 |
Reneman L, Booij J, Habraken JB, De Bruin K, Hatzidimitriou G, Den Heeten GJ, Ricaurte GA. Validity of [123I]beta-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity. Synapse (New York, N.Y.). 46: 199-205. PMID 12325046 DOI: 10.1002/Syn.10130 |
0.67 |
|
| 2002 |
Haddad PM, Strickland P, Anderson I, Deakin JFW, Dursun SM, Ratzenböck E, Reneman L, Booij J, Den Heeten GJ, Van Den Brink W. Effects of MDMA (ecstasy) use and abstention on serotonin neurons [1] (multiple letters) Lancet. 359: 1616-1618. PMID 12047988 DOI: 10.1016/S0140-6736(02)08490-8 |
0.639 |
|
| 2002 |
Reneman L, Booij J, Lavalaye J, de Bruin K, Reitsma JB, Gunning B, den Heeten GJ, van Den Brink W. Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report. Psychopharmacology. 159: 335-40. PMID 11862367 DOI: 10.1007/S00213-001-0930-0 |
0.721 |
|
| 2002 |
Reneman L, Endert E, de Bruin K, Lavalaye J, Feenstra MG, de Wolff FA, Booij J. The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 387-96. PMID 11850153 DOI: 10.1016/S0893-133X(01)00366-9 |
0.487 |
|
| 2002 |
Reneman L, Majoie CB, Flick H, den Heeten GJ. Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results. Ajnr. American Journal of Neuroradiology. 23: 231-7. PMID 11847047 |
0.569 |
|
| 2002 |
Reneman L, Booij J, Schmand B, Reitsma JB, De Wolff FA, Gunning WB, Den Heeten GJ, Van Den Brink W. Short- and long-term effects of ecstasy on serotonin-producing cells in the brain and on memory | Korte- en langetermijneffecten van ecstasy op serotonineproducerende hersencellen en het geheugen Nederlands Tijdschrift Voor Geneeskunde. 146: 2240-2246. |
0.732 |
|
| 2001 |
Reneman L, Booij J, Majoie CB, Van Den Brink W, Den Heeten GJ. Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach. Human Psychopharmacology. 16: 579-588. PMID 12404537 DOI: 10.1002/Hup.347 |
0.732 |
|
| 2001 |
Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet. 358: 1864-9. PMID 11741626 DOI: 10.1016/S0140-6736(01)06888-X |
0.796 |
|
| 2001 |
Reneman L, Majoie CB, Schmand B, van den Brink W, den Heeten GJ. Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report. Biological Psychiatry. 50: 550-4. PMID 11600108 DOI: 10.1016/S0006-3223(01)01177-5 |
0.591 |
|
| 2001 |
Reneman L, Lavalaye J, Schmand B, de Wolff FA, van den Brink W, den Heeten GJ, Booij J. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings. Archives of General Psychiatry. 58: 901-6. PMID 11576026 DOI: 10.1001/Archpsyc.58.10.901 |
0.72 |
|
| 2001 |
Reneman L, Majoie CB, Habraken JB, den Heeten GJ. Effects of ecstasy (MDMA) on the brain in abstinent users: initial observations with diffusion and perfusion MR imaging. Radiology. 220: 611-7. PMID 11526257 DOI: 10.1148/Radiol.2202001602 |
0.596 |
|
| 2001 |
Lavalaye J, Booij J, Linszen DH, Reneman L, van Royen EA. Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia. A[123I]-IDEX SPECT study. Psychopharmacology. 156: 53-7. PMID 11465633 DOI: 10.1007/S002130000679 |
0.645 |
|
| 2001 |
Lavalaye J, Sarlet A, Booij J, Linszen DH, Reneman L, Gersons BP, van Royen EA. Dopamine transporter density in patients with tardive dyskinesia: a single photon emission computed tomography study. Psychopharmacology. 155: 107-9. PMID 11374328 DOI: 10.1007/S002130000670 |
0.647 |
|
| 2001 |
Reneman L, De Bruin K, Lavalaye J, Gunning WB, Booij J. Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus. Synapse (New York, N.Y.). 39: 193-200. PMID 11169768 DOI: 10.1002/1098-2396(20010301)39:3<193::Aid-Syn1000>3.0.Co;2-F |
0.753 |
|
| 2001 |
Lavalaye J, Linszen DH, Booij J, Dingemans PM, Reneman L, Habraken JB, Gersons BP, van Royen EA. Dopamine transporter density in young patients with schizophrenia assessed with [123]FP-CIT SPECT. Schizophrenia Research. 47: 59-67. PMID 11163545 DOI: 10.1016/S0920-9964(00)00023-2 |
0.646 |
|
| 2000 |
Lavalaye J, Booij J, Reneman L, Habraken JB, van Royen EA. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. European Journal of Nuclear Medicine. 27: 867-9. PMID 10952500 DOI: 10.1007/S002590000279 |
0.662 |
|
| 2000 |
Reneman L, Habraken JB, Majoie CB, Booij J, den Heeten GJ. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings. Ajnr. American Journal of Neuroradiology. 21: 1001-7. PMID 10871002 |
0.655 |
|
| 2000 |
Lavalaye J, Knol RJ, de Bruin K, Reneman L, Janssen AG, Booij J. [123I]FP-CIT binding in rat brain after acute and sub-chronic administration of dopaminergic medication. European Journal of Nuclear Medicine. 27: 346-9. PMID 10774889 DOI: 10.1007/S002590050044 |
0.513 |
|
| 2000 |
Reneman L, Booij J, Schmand B, van den Brink W, Gunning B. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology. 148: 322-4. PMID 10755746 DOI: 10.1007/S002130050057 |
0.61 |
|
| 1999 |
Lavalaye J, Linszen DH, Booij J, Reneman L, Gersons BP, van Royen EA. Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia. Psychiatry Research. 92: 33-44. PMID 10688158 DOI: 10.1016/S0925-4927(99)00032-3 |
0.64 |
|
| 1999 |
Reneman L, Booij J, Lavalaye J, De Bruin K, De Wolff FA, Koopmans RP, Stoof JC, Den Heeten GJ. Comparative in vivo study of iodine-123-labeled beta-CIT and nor-beta-CIT binding to serotonin transporters in rat brain. Synapse (New York, N.Y.). 34: 77-80. PMID 10459174 DOI: 10.1002/(Sici)1098-2396(199910)34:1<77::Aid-Syn9>3.0.Co;2-Y |
0.642 |
|
| 1998 |
Booij J, Knol RJ, Reneman L, de Bruin K, Janssen AG, van Royen EA. Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats. European Journal of Nuclear Medicine. 25: 1666-9. PMID 9871099 DOI: 10.1007/S002590050346 |
0.641 |
|
| Show low-probability matches. |